AUSTIN, Texas, March 25, 2024 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced ...
Plus Therapeutics (PSTV) announces three positive clinical data update presentations at the World Federation of Neuro-Oncology Societies/Society ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback